Optimization of treatment outcome and exploration of new indication in anti-vascular endothelial growth factor therapy
10.3760/cma.j.issn.1005-1015.2015.01.002
- VernacularTitle:积极稳妥地进行治疗效果优化及新适应证探索研究,不断提高科学使用抗血管内皮生长因子药物治疗眼底病的临床应用水平
- Author:
Xun XU
- Publication Type:Journal Article
- Keywords:
Angiogenesis inhibitors/therapeutic use;
Antibodies,monoclonal/therapeutic use;
Choroidal neovascularization/drug therapy;
Retinal neovascularization/drug therapy
- From:
Chinese Journal of Ocular Fundus Diseases
2015;31(1):3-5
- CountryChina
- Language:Chinese
-
Abstract:
Since anti vascular endothelial growth factor (VEGF) therapy has recently become the first-line treatment of wet age related macular degeneration in China,as well as retinopathy of prematurity,neovascular glaucoma and macular edema secondary to diabetic retinopathy or retinal vein occlusion in other countries,It is worth thinking about that how to perform anti-VEGF treatment properly to benefit more patients.We reviewed the fields of clinical researches to explore the best role of anti-VEGF treatment in prevention and treatment of retinal disease in future.
